PlainRecalls
FDA Drug Moderate Class II Terminated

Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only, MFG: Ascend Labs, LLC, Montvale, NJ 07645

Reported: January 12, 2022 Initiated: December 29, 2021 #D-0360-2022

Product Description

Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only, MFG: Ascend Labs, LLC, Montvale, NJ 07645

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
a) 716 bottles/ 1432 capsules b) 223 blister packs/ 466 capsules
Distribution
Product was distributed to two direct accounts in MI and PA.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only, MFG: Ascend Labs, LLC, Montvale, NJ 07645. Recalled by RemedyRepack Inc.. Units affected: a) 716 bottles/ 1432 capsules b) 223 blister packs/ 466 capsules.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on January 12, 2022. Severity: Moderate. Recall number: D-0360-2022.